Next-gen gene editing, Keith Gottesdiener, President & CEO, Jeremy Duffield, CSO, Prime Medicine
Synopsis: Keith Gottesdiener, MD, and Jeremy Duffield, MD, PhD, FRCP, are the President & CEO and CSO, respectively, of Prime Medicine. Prime Medicine was founded to bring the promise of gene editing...
22 Nov 202340min
Developing medicines for broad populations of cancer patients, Brett Hall, CSO, Immuneering
Synopsis: Brett Hall, Ph.D., is the CSO of Immuneering, a public, clinical-stage oncology company dedicated to developing medicines for broad populations of cancer patients by applying its deep knowl...
15 Nov 202341min
Harnessing the power of microglia, Ivana Magovčević-Liebisch, President & CEO, Vigil Neuroscience
Synopsis: Ivana Magovčević-Liebisch, PhD, JD, is the President and CEO of Vigil Neuroscience, a microglia-focused company dedicated to improving the lives of patients, caregivers, and families affect...
8 Nov 202325min
Revolutionizing eyecare treatment, Bobak Azamian, CEO & Chairman, Tarsus Pharmaceuticals
Synopsis: Bobak Azamian, MD, Ph.D., is the CEO and Chairman of Tarsus Pharmaceuticals, a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patien...
1 Nov 202326min
Targeting validated drivers of cancer, Nima Farzan, CEO, Kinnate Biopharma
Synopsis: Nima Farzan is the CEO of Kinnate Biopharma, a clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer. The company is ...
25 Okt 202329min
Advancing bold therapies for neuronal health, Mark Litton, President & CEO, Athira Pharma
Synopsis: Mark Litton, Ph.D., is the President and CEO of Athira Pharma, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neur...
18 Okt 202329min
Pioneering RNA editing to deliver the future of medicine, Ram Aiyar, President & CEO, Korro Bio
Synopsis: Ram Aiyar, Ph.D., MBA, is the President & CEO of Korro Bio. Korro Bio harnesses the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function,...
11 Okt 202327min
Unlocking the technological potential of biology, Seemay Chou, Co-Founder & CEO, Arcadia Science
Synopsis: Seemay Chou, Ph.D., is the Co-Founder and CEO of Arcadia Science, a research and development company leveraging the biology of emerging research organisms. Seemay sits down with Alok to dis...
4 Okt 202344min
